BMY
45
-6
XYL
39
6
NRG
67
-2
DNB
60
-2
KSS
26
-3
MCK
77
2
RF
70
3
NEE
46
-3
WHR
47
-3
UHS
67
3
NAVI
36
-4
EMN
46
-2
MRK
30
-8
EIX
42
-3
JNJ
50
-3
SYK
40
-4
MPC
47
3
AEP
69
-3
BBY
36
-2
EXPE
78
-2
BMY
45
-6
XYL
39
6
NRG
67
-2
DNB
60
-2
KSS
26
-3
MCK
77
2
RF
70
3
NEE
46
-3
WHR
47
-3
UHS
67
3
NAVI
36
-4
EMN
46
-2
MRK
30
-8
EIX
42
-3
JNJ
50
-3
SYK
40
-4
MPC
47
3
AEP
69
-3
BBY
36
-2
EXPE
78
-2
Financhill
Back

The Cooper Companies 10K Form

Buy
60

COO
The Cooper Companies

Last Price:
$83.57
Seasonality Move:
7.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COO News And Ratings

See the #1 stock for the next 7 days that we like better than COO

COO Financial Statistics

Sales & Book Value

Annual Sales: $3.9B
Cash Flow: $101.2M
Price / Cash Flow: 43.68
Annual Sales: $40.66
Price / Book: 2.06

Profitability

EPS (TTM): 2.06000
Net Income (TTM): $415.4M
Gross Margin: $2.6B
Return on Equity: 5.24%
Return on Assets: 3.42%

The Cooper Companies Earnings Forecast

Key The Cooper Companies Financial Ratios

  • The Gross Profit Margin over the past 41 years for COO is 66.64%.
  • The Selling, General & Administrative Expenses for COO have been equal to 39.37% of Gross Profit Margin.
  • The Research & Development expenses have been 3.98% of Revenue.
  • The Interest Expense is 29.14% of Operating Income.
  • The Net Earning history of COO is 10.07% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 26 years.

The Cooper Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: COO
CUSIP: 216648
Website: coopercos.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 1.99
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 42.7
Forward P/E Ratio: 18.9

COO Technical Analysis vs Fundamental Analysis

Buy
60
The Cooper Companies (COO) is a Buy

Is The Cooper Companies a Buy or a Sell?